Chinese scientists synthesize starch from CO2 for the first time

A group of Chinese scientists has synthesized starch from carbon dioxide for the first time in the world, local media report.

SIGHT: The COVID-19 pandemic has not slowed climate change

The study has been carried out by the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences, and has been published in the journal Science.

According to the Institute, the starch of human consumption and requires for its obtaining “A large amount of land, fresh water and other resources, as well as agricultural production materials such as fertilizers and pesticides.”

SIGHT: Climate change: the Earth faces a record of days that exceed 50º C

The study shows that this synthetic carbon dioxide starch could be more profitable than traditional crops, since it could save in addition to “Reduce the impact of fertilizers and pesticides” in the environment.

Compared to corn, one of the most common sources of this nutrient, the rate of starch synthesis using this artificial form is 8.5 times higher, according to the study.

SIGHT: “They are evolving to survive”: animals change shape due to climate change

Six years ago, the Institute created a working group exclusively dedicated to the development of projects related to synthetic starch.

According to statements by the Institute, Ma Yanhe, collected in local media, “For a long time, researchers have tried to improve the process of photosynthesis, hoping to increase the conversion rate of carbon dioxide and the achievement that allows your group “Improve the efficiency of starch production.”

In September, Chinese President Xi Jinping set a Chinese goal of reaching peak carbon emissions by 2030.

China is the country responsible for the highest amount of carbon dioxide emissions in the world (27% of the global total in 2017, according to the Global Carbon Atlas).

• The COVID-19 pandemic has not slowed climate change
• Delta Plus variant of the coronavirus: More contagious and resistant to vaccines?
• Pfizer begins testing of a COVID-19 pill
• Third wave: 5 things we know about COVID-19 that will help us cope with a spike in cases
• COVID-19 | Patients who come to the ICU are mostly men and have more antibodies
• COVID-19 | Results of the Sinopharm clinical trial conducted in Peru will be “very soon”
• Sinopharm will be accepted to travel to the US: reasons to trust the Chinese vaccine
• What are “rogue” antibodies and what do they have to do with severe COVID-19?
• What will the third year of the pandemic be like ?, by Elmer Huerta
• COVID-19 | New Chinese vaccine is 79% effective against Delta variant
• COVID-19 May Look Like a Cold in the Future, AstraZeneca Developer Says
• Delta variant of COVID-19 is now predominant in Peru: five things you should know
• COVID-19 | Europe will decide in October whether to authorize Pfizer’s booster dose
• Sinopharm will be accepted to travel to the US: reasons to trust the Chinese vaccine
• COVID-19 | How close are we to the end of the pandemic?
• Who will the third dose of Pfizer reach in the US?
• COVID-19 infection may precede Guillain-Barré syndrome in rare cases
• COVID-19 | “It is a harm to public health for someone to apply more than two doses on their own”
• COVID-19 | Six billion doses of vaccines have been administered worldwide
• They find a virus very similar to that of COVID-19 in bats of Laos
• Brazil and Argentina will produce mRNA vaccines against COVID-19 for the region, PAHO announces
• Convalescent Plasma: Does This Therapy Work To Treat COVID-19 Patients?

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn